110
Views
0
CrossRef citations to date
0
Altmetric
Short Report

Determining Persistence with an Inhaled Corticosteroid in Asthma: Assessment Using an Objective Measurement vs the Self-Reported Foster Score

, , , ORCID Icon & ORCID Icon
Pages 25-33 | Published online: 05 Jan 2022

References

  • Global Initiative for Asthma. Global strategy for asthma management and prevention, 2020; 2020. Available from: www.ginasthma.org. Accessed December 29, 2021.
  • Sabaté E. Adherence to Long-Term Therapies Evidence for Action. WHO; 2003.
  • Statista. Number of individuals with asthma in Denmark from 2008 to 2018. Available from: https:// www.statista.com/ statistics/950546/ number- ofindividuals-with-asthma-in-denmark/. Accessed December 29, 2021.
  • Engelkes M, Janssens HM, De Jongste JC, Sturkenboom MCJM, Verhamme KMC. Medication adherence and the risk of severe asthma exacerbations: a systematic review. Eur Respir J. 2015;45(2):396–407. doi:10.1183/09031936.00075614
  • McDonald VM, Yorke J. Adherence in severe asthma: time to get it right. Eur Respir J. 2017;50(6):1702191. doi:10.1183/13993003.02191-2017
  • Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Curr Med Res Opin. 2009;25(9):2303–2310. doi:10.1185/03007990903126833
  • Lasmar L, Camargos P, Champs N, et al. Adherence rate to inhaled corticosteroids and their impact on asthma control. Allergy. 2009;64(5):784–789. doi:10.1111/J.1398-9995.2008.01877.X
  • Mäkelä MJ, Backer V, Hedegaard M, Larsson K. Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD. Respir Med. 2013;107(10):1481–1490. doi:10.1016/j.rmed.2013.04.005
  • Bae YJ, Kim TB, Jee YK, et al. Severe asthma patients in Korea overestimate their adherence to inhaled corticosteroids. J Asthma. 2009;46(6):591–595. doi:10.1080/02770900902980908
  • Hesso I, Nabhani Gebara S, Greene G, Co Stello RW, Kayyali R. A quantitative evaluation of adherence and inhalation technique among respiratory patients: an observational study using an electronic inhaler assessment device. Int J Clin Pract. 2020;74(2):e13437. doi:10.1111/ijcp.13437
  • Erickson SR, Coombs JH, Kirking DM, Azimi AR. Compliance from self-reported versus pharmacy claims data with metered-dose inhalers. Ann Pharmacother. 2001;35(9):997–1003. doi:10.1345/aph.10379
  • Van Steenis MNA, Driesenaar JA, Bensing JM, et al. Relationship between medication beliefs, self-reported and refill adherence, and symptoms in patients with asthma using inhaled corticosteroids. Patient Prefer Adherence. 2014;8:83–91. doi:10.2147/PPA.S44185
  • Moran C, Doyle F, Sulaiman I, et al. The INCATM (Inhaler Compliance AssessmentTM): a comparison with established measures of adherence. Psychol Heal. 2017;32(10):1266–1287. doi:10.1080/08870446.2017.1290243
  • von Bülow A, Backer V, Bodtger U, et al. Differentiation of adult severe asthma from difficult-to-treat asthma – outcomes of a systematic assessment protocol. Respir Med. 2018;145:41–47. doi:10.1016/j.rmed.2018.10.020
  • Vähätalo I, Ilmarinen P, Tuomisto LE, et al. 12-year adherence to inhaled corticosteroids in adult-onset asthma. ERJ Open Res. 2020;6(1):00324–02019. doi:10.1183/23120541.00324-2019
  • Williams LK, Pladevall M, Xi H, et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol. 2004;114(6):1288–1293. doi:10.1016/j.jaci.2004.09.028
  • D’Amato G, Vitale C, Molino A, et al. Asthma-related deaths. Multidiscip Respir Med. 2016;11(1):1–5. doi:10.1186/s40248-016-0073-0
  • von Bülow A, Urik CS, Sidenius K, et al. Astma - Svær - Udredning og behandling af patienter med mulig svær astma. [Asthma - Severe - Investigation and treatment of patients with possible severe asthma]. Available from: https://https://lungemedicin.dk/astma-svaer-udredning-og-behandling-af-patienter-med-mulig-svaer-astma/. Accessed December 29, 2021.
  • Martin BC, Wiley-Exley EK, Richards S, Domino ME, Carey TS, Sleath BL. Contrasting measures of adherence with simple drug use, medication switching, and therapeutic duplication. Ann Pharmacother. 2009;43(1):36–44. doi:10.1345/aph.1K671
  • Kang HR, Song HJ, Nam JH, et al. Risk factors of asthma exacerbation based on asthma severity: a nationwide population-based observational study in South Korea. BMJ Open. 2018;8(3):e020825. doi:10.1136/bmjopen-2017-020825
  • Jensen FF, Håkansson KEJ, Nielsen BO, Weinreich UM, Ulrik CS. Self-reported vs. objectively assessed adherence to inhaled corticosteroids in asthma. Asthma Res Pract. 2021;7(1):1–9. doi:10.1186/s40733-021-00072-2
  • Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44–47. doi:10.1111/j.1524-4733.2007.00213.x
  • Stirratt MJ, Dunbar-Jacob J, Crane HM, et al. Self-report measures of medication adherence behavior: recommendations on optimal use. Transl Behav Med. 2015;5(4):470–482. doi:10.1007/s13142-015-0315-2
  • Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113(1):59–65. doi:10.1016/j.jaci.2003.09.008
  • Juniper EF, O’Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14(4):902–907. doi:10.1034/j.1399-3003.1999.14d29.x
  • Schatz M, Sorkness CA, Li JT, et al. Asthma control test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol. 2006;117(3):549–556. doi:10.1016/j.jaci.2006.01.011
  • Athanazio R, Carvalho-Pinto R, Fernandes FLA, et al. Can severe asthmatic patients achieve asthma control? A systematic approach in patients with difficult to control asthma followed in a specialized clinic. BMC Pulm Med. 2016;16(1):1–8. doi:10.1186/s12890-016-0314-1
  • Dewitte K, Fierens C, Stöckl D, Thienpont LM. Application of the bland–Altman plot for interpretation of method-comparison studies: a critical investigation of its practice. Clin Chem. 2002;48(5):799–801. doi:10.1093/clinchem/48.5.799
  • Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155–163. doi:10.1016/j.jcm.2016.02.012
  • Williams LK, Peterson EL, Wells K, et al. Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence. J Allergy Clin Immunol. 2011;128(6):1185. doi:10.1016/j.jaci.2011.09.011
  • Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;(2). doi:10.1002/14651858.CD000011.pub3
  • Laforest L, Belhassen M, Devouassoux G, Didier A, Ginoux M, Van Ganse E. Long-term inhaled corticosteroid adherence in asthma patients with short-term adherence. J Allergy Clin Immunol Pract. 2016;4(5):890–899.e2. doi:10.1016/j.jaip.2016.07.008
  • Covvey JR, Mullen AB, Ryan M, et al. A comparison of medication adherence/persistence for asthma and chronic obstructive pulmonary disease in the United Kingdom. Int J Clin Pract. 2014;68(10):1200–1208. doi:10.1111/ijcp.12451
  • Bårnes CB, Ulrik CS. Asthma and adherence to inhaled corticosteroids: current status and future perspectives. Respir Care. 2015;60(3):455–468. doi:10.4187/respcare.03200
  • Jordan A, Sivapalan P, Jensen J-U. Does inhaled corticosteroid use affect the risk of COVID-19-related death? Breathe. 2021;17(1):200275. doi:10.1183/20734735.0275-2020
  • Cohen JL, Mann DM, Wisnivesky JP, et al. Assessing the validity of self-reported medication adherence among inner-city asthmatic adults: the medication adherence report scale for asthma. Ann Allergy Asthma Immunol. 2009;103(4):325–331. doi:10.1016/S1081-1206(10)60532-7
  • Skurtveit S, Selmer R, Tverdal A, Furu K. The validity of self-reported prescription medication use among adolescents varied by therapeutic class. J Clin Epidemiol. 2008;61(7):714–717. doi:10.1016/j.jclinepi.2007.11.013
  • Laforest L, El Hasnaoui A, Pribil C, et al. Asthma patients’ self-reported behaviours toward inhaled corticosteroids. Respir Med. 2009;103(9):1366–1375. doi:10.1016/j.rmed.2009.03.010
  • Foster JM, Smith L, Bosnic-Anticevich SZ, et al. Identifying patient-specific beliefs and behaviours for conversations about adherence in asthma. Intern Med J. 2012;42(6):e136–e144. doi:10.1111/j.1445-5994.2011.02541.x
  • Kildemoes HW, Sørensen HT, Hallas J. The Danish national prescription registry. Scand J Public Health. 2011;39(7 Suppl):38–41. doi:10.1177/1403494810394717
  • Giavarina D. Understanding Bland Altman analysis. Biochem Med. 2015;25(2):141–151.
  • Plaza V, Fernández-Rodríguez C, Melero C, et al. Validation of the “Test of the Adherence to Inhalers” (TAI) for asthma and COPD patients. J Aerosol Med Pulm Drug Deliv. 2016;29(2):142–152. doi:10.1089/jamp.2015.1212
  • Dima AL, van Ganse E, Laforest L, Texier N, de Bruin M. Measuring medication adherence in asthma: development of a novel self-report tool. Psychol Health. 2017;32(10):1288–1307. doi:10.1080/08870446.2017.1290248
  • Matza LS, Park J, Coyne KS, Skinner EP, Malley KG, Wolever RQ. Derivation and validation of the ASK-12 adherence barrier survey. Ann Pharmacother. 2009;43(10):1621–1630. doi:10.1345/aph.1M174
  • Andrade SE, Kahler KH, Frech F, Chan KA. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006;15(8):565–574. doi:10.1002/pds.1230